Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jan 4, 2008

WuXi PharmaTech to Acquire AppTec Laboratory Services for $151M

  • WuXi PharmaTech plans to buy AppTec Laboratory Services in a deal valued at $151 million. The acquisition adds biologics capabilities to WuXi PharmaTech’s services. The firm will also gain a significant U.S. operational footprint.

    It is expected that the combined business operations of WuXi PharmaTech and AppTec in the U.S. and China will enable WuXi PharmaTech to provide a full-service suite of outsourced chemistry and biology services to global pharmaceutical, biotechnology, and medical device clients.



Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »